1. Secukinumab improves the signs and symptoms of moderate‐to‐severe plaque psoriasis in subjects with involvement of hands and/or feet: subanalysis of a randomized, double‐blind, placebo‐controlled, phase 2 dose‐ranging study. (13th December 2013) Authors: Sigurgeirsson, B.; Kircik, L.; Nemoto, O.; Mikazans, I.; Haemmerle, S.; Thurston, H.J.; Papavassilis, C.; Richards, H.B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 8(2014:Aug.) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗